RO5323441
BP25497
Phase 1 small_molecule completed
Quick answer
RO5323441 for Carcinoma, Hepatocellular is a Phase 1 program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Carcinoma, Hepatocellular
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed